Evidence mapPaperPMID 33215566Full record

ArticleJournal of the American Heart Association2020

Plasminogen Deficiency and Amiloride Mitigate Angiotensin II-Induced Hypertension in Type 1 Diabetic Mice Suggesting Effects Through the Epithelial Sodium Channel.

Henrik Andersen, Maria Høj Hansen, Kristian B Buhl, Mette Stæhr, Ulla G Friis, Camilla Enggaard, Shanya Supramaniyam, Ida K Lund, Per Svenningsen, Pernille B L Hansen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. The Epithelial Sodium Channel-An Underestimated Drug Target.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Henrik AndersenDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Maria Høj HansenDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Kristian B BuhlDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Mette StæhrDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Ulla G FriisDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Camilla EnggaardDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Shanya SupramaniyamDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Ida K LundThe Finsen Laboratory Copenhagen University Hospital, and Biotech Research and Innovation Center (BRIC) University of Copenhagen Denmark.
Per SvenningsenDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Pernille B L HansenDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
Boye L JensenDepartment of Cardiovascular and Renal Research Institute of Molecular Medicine University of Southern Denmark Odense Denmark.
University of Southern Denmark · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Diabetic nephropathy is a common diabetes mellitus complication associated with hypertension, proteinuria, and excretion of urinary plasmin that activates the epithelial sodium channel, ENaC,

Indexed as

AmilorideAngiotensin IIAnimalsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Epithelial Sodium Channel BlockersEpithelial Sodium ChannelsHypertensionMaleMicePlasminogenAmilorideAngiotensin IIEpithelial Sodium Channel BlockersEpithelial Sodium ChannelsPlasminogenalbuminuriaaldosteroneproteasereninsodium channels

Identifiers

PMID33215566
PMCPMC7763785
OpenAlexW3099915521

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.